Jason Bradley Terrell

US Patent:

20230051905, Feb 16, 2023

Filed:

Aug 25, 2022

Appl. No.:

17/895953

Inventors:

- Isnes, BE
Mark Edward ECCLESTON - London, GB
Jason Bradley TERRELL - Austin TX, US

International Classification:

G01N 33/68

Abstract:

The invention relates to using cell free nucleosome levels to identify patients at risk of developing a NETosis associated adverse reaction to the infection. The methods are used to monitor the progress of a disease and assigning a risk of an adverse outcome in a patient suffering from an infection.

US Patent:

20200182875, Jun 11, 2020

Filed:

Jul 25, 2017

Appl. No.:

16/320440

Inventors:

- Isnes, BE
Jason Terrell - Austin TX, US

Assignee:

Belgian Volition SPRL - Isnes,

International Classification:

G01N 33/574
G01N 33/68
G01N 33/72

Abstract:

The present invention relates to methods of detecting and/or screening for colorectal cancer (CRC), a colorectal adenoma or a polyp in a patient comprising identifying patients found to be positive for fecal occult blood and further testing for one or more additional factors. Said methods can be used to assess the suitability of a patient for colonoscopy.

US Patent:

20180321157, Nov 8, 2018

Filed:

May 4, 2018

Appl. No.:

15/971887

Inventors:

Jason B. Terrell - Burnet TX, US

International Classification:

G01N 21/76
G01N 1/31
B65D 83/20
B65D 83/68
B65D 83/14

Abstract:

The present invention relates to a system and method for a liquid containing compound/s producing a visible chemiluminescent glow upon being distributed in the atmosphere in the presents of a targeted analyte. It is an object of the present invention to provide a system and method for discharging a chemiluminescent spray into the atmosphere, upon which, in the event of the presence of an analyte, such as H2S, a chemiluminescent reaction occurs.